HMGCR and cancer: This observation is significant because we have proposed that relatively high doses of statins will be necessary to treat cancer to provide an adequate plasma concentration (microMolar) of the drug in patients, leading to the concern that high concentrations of pitavastatin might be cytotoxic through a mechanism other than inhibition of HMGCR.